Key result
Beta-blockers are an efficacious and well-tolerated treatment for heart failure, with recent studies suggesting these benefits extend to the elderly patient population despite clinical underutilization.
Why the study?
Are beta-blockers efficacious and well-tolerated in elderly patients with systolic chronic heart failure?
Are beta-blockers efficacious and well-tolerated in elderly patients with systolic chronic heart failure?
Beta-blockers are efficacious and well-tolerated in elderly patients with heart failure, and their underutilization in this population should be addressed.
No takes yet. Share an insight, caveat, or question.
Supports addressing beta-blocker underutilization in elderly HF; leaves open need for dedicated RCTs.
Zimmet et al. (2006) conducted a review in Heart failure. Beta-blockers was evaluated. Beta-blockers are an efficacious and well-tolerated treatment for heart failure, with recent studies suggesting these benefits extend to the elderly patient population despite clinical underutilization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: